Digitalis cardiotoxicity.

J Am Coll Cardiol

Published: May 1985

Clinical manifestations of digitalis toxicity were clearly described by Withering in 1785. One hundred years later, certain digitalis-induced arrhythmias were inscribed on the smoked drum, and shortly thereafter with the introduction of the electrocardiograph, manifestations of digitalis toxicity as recognized today were recorded in animals and human beings. With popularization of the direct-writing electrocardiograph in the late 1940s and the introduction of digitoxin in recommended doses (that in retrospect appear inappropriately high), the documented prevalence of digitalis toxicity increased rapidly. With increased understanding of the interaction of electrolytes and digitalis and perhaps, and more importantly, the widespread use of digoxin in doses derived largely from its inotropic action and, thus, inappropriately low for the management of many of the arrhythmias, the prevalence of digitalis toxicity began to decline again. In addition, the advent of serum level determinations and the widespread acceptance of the concept of "therapeutic" levels which, although frequently falling short of the desired clinical end point, served to preclude digitalis toxicity. With the decline in the incidence of digitalis toxicity consequent to these factors, some of the digitalis-related arrhythmias that were common are now rarely observed. This report focuses on arrhythmias that are highly specific for digitalis toxicity and on those that now are less commonly encountered. The discussion and classification of the arrhythmias are based on their most probable electrophysiologic mechanism.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0735-1097(85)80467-8DOI Listing

Publication Analysis

Top Keywords

digitalis toxicity
28
digitalis
9
manifestations digitalis
8
prevalence digitalis
8
toxicity
7
arrhythmias
5
digitalis cardiotoxicity
4
cardiotoxicity clinical
4
clinical manifestations
4
toxicity clearly
4

Similar Publications

Article Synopsis
  • - Nonparoxysmal junctional tachycardia with Wenckebach exit block is usually linked to digitalis toxicity.
  • - This report highlights a case where the arrhythmia appeared without the use of digitalis medication.
  • - The patient in this case had underlying structural heart disease, suggesting that other factors may trigger this type of arrhythmia.
View Article and Find Full Text PDF
Article Synopsis
  • - Digoxin is a cardiac medication that works by blocking the sodium potassium ATPase pump, but it has a very narrow therapeutic range, meaning the amount in the body needs to be tightly monitored.
  • - Factors like age, body weight, kidney and liver function, and other medications can affect digoxin levels in the blood, increasing the risk of toxicity, which can lead to serious heart rhythm issues.
  • - A case study of an elderly man showed that digoxin toxicity, exacerbated by chronic kidney disease and lack of dose adjustment, led to fainting and a mild brain injury, highlighting the dangers of improper management of digoxin in vulnerable populations.
View Article and Find Full Text PDF
Article Synopsis
  • Saponins are toxic compounds found in plants that help defend against pests and pathogens, with known mechanisms for fungal resistance focused on enzyme secretion.
  • Researchers investigated how the fungus Botrytis cinerea tolerates specific saponins from tomato and Digitalis purpurea, discovering four mechanisms that help it overcome the toxicity.
  • One novel mechanism involves enzymatic deglycosylation, while the others function in the fungal membrane, suggesting implications for understanding tolerance in both plant pathogenic fungi and potential human pathogens.
View Article and Find Full Text PDF
Article Synopsis
  • Bidirectional ventricular tachycardia (BVT) is a rare and serious heart rhythm issue marked by changes in the QRS axis with each heartbeat, often linked to digitalis toxicity.
  • A 62-year-old woman who had heart surgery developed BVT after being treated with digoxin and diuretics, leading to concerns about the interaction between these medications.
  • The case stresses the need for careful monitoring of digoxin levels in patients on diuretics and suggests supportive treatments if BVT occurs, like stopping digoxin and providing potassium and magnesium supplements.
View Article and Find Full Text PDF

"Cardiac glycosides"-quo vaditis?-past, present, and future?

Naunyn Schmiedebergs Arch Pharmacol

December 2024

Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Straße 9, 97078, Würzburg, Germany.

Article Synopsis
  • Digitalis glycosides, or cardiac glycosides, are drugs that inhibit the Na/K-ATPase and are commonly used to treat heart failure and atrial fibrillation.
  • Despite their effectiveness, these drugs have a narrow therapeutic range, leading to debates about their necessity and safety in these conditions.
  • The article aims to review the historical context, key research findings, and the overlooked advantages and disadvantages of using digitalis glycosides in clinical practice.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!